A detailed history of Resonant Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 101,864 shares of PFE stock, worth $3.05 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
101,864
Previous 97,898 4.05%
Holding current value
$3.05 Million
Previous $2.82 Million 0.28%
% of portfolio
0.24%
Previous 0.27%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $102,679 - $117,909
3,966 Added 4.05%
101,864 $2.83 Million
Q4 2023

Jan 31, 2024

BUY
$26.13 - $33.94 $255,081 - $331,322
9,762 Added 11.08%
97,898 $2.82 Million
Q3 2023

Oct 31, 2023

BUY
$32.09 - $37.51 $41,171 - $48,125
1,283 Added 1.48%
88,136 $2.92 Million
Q2 2023

Jul 25, 2023

BUY
$36.12 - $41.79 $24,128 - $27,915
668 Added 0.78%
86,853 $3.19 Million
Q1 2023

Apr 21, 2023

BUY
$39.39 - $51.28 $2,205 - $2,871
56 Added 0.07%
86,185 $3.52 Million
Q4 2022

Jan 23, 2023

BUY
$41.75 - $54.5 $147,043 - $191,949
3,522 Added 4.26%
86,129 $0
Q3 2022

Oct 20, 2022

SELL
$43.76 - $53.42 $83,362 - $101,765
-1,905 Reduced 2.25%
82,607 $3.62 Million
Q2 2022

Jul 12, 2022

BUY
$46.53 - $55.17 $35,502 - $42,094
763 Added 0.91%
84,512 $4.43 Million
Q1 2022

Apr 19, 2022

BUY
$45.75 - $56.69 $184,098 - $228,120
4,024 Added 5.05%
83,749 $4.32 Million
Q4 2021

Jan 26, 2022

BUY
$41.32 - $61.25 $258,911 - $383,792
6,266 Added 8.53%
79,725 $4.71 Million
Q3 2021

Oct 18, 2021

BUY
$39.25 - $50.42 $291,470 - $374,418
7,426 Added 11.25%
73,459 $3.16 Million
Q2 2021

Jul 16, 2021

BUY
$35.91 - $40.68 $5,422 - $6,142
151 Added 0.23%
66,033 $2.59 Million
Q1 2021

Apr 28, 2021

BUY
$33.49 - $37.77 $156,934 - $176,990
4,686 Added 7.66%
65,882 $2.39 Million
Q4 2020

Jan 15, 2021

BUY
$33.47 - $42.56 $74,202 - $94,355
2,217 Added 3.76%
61,196 $2.25 Million
Q3 2020

Nov 03, 2020

BUY
$31.75 - $37.25 $23,939 - $28,086
754 Added 1.29%
58,979 $2.17 Million
Q2 2020

Aug 05, 2020

SELL
$30.12 - $36.54 $352,404 - $427,518
-11,700 Reduced 16.73%
58,225 $1.9 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $90,253 - $128,952
3,339 Added 5.01%
69,925 $2.28 Million
Q4 2019

Feb 18, 2020

BUY
$32.92 - $37.36 $2.19 Million - $2.49 Million
66,586 New
66,586 $2.61 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $168B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Resonant Capital Advisors, LLC Portfolio

Follow Resonant Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.